Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities

Sahana Bettadapura, Katherine Dowling, Kelli Jablon, Ahmed W Al-Humadi, Carel W le Roux

Research output: Contribution to journalArticlepeer-review

11 Downloads (Pure)

Abstract

Glucagon-like peptide-1 (GLP-1) analogs are approved for the treatment of obesity in adults and adolescents. Reports have emerged that the weight loss effect of these medications may be related to changes in food preferences and ingestive behaviors following the treatment. Understanding the mechanisms which impact ingestive behavior could expand opportunities to develop more refined and personalized treatment options for obesity. Recent studies investigating the relationship between GLP-1 analogs and ingestive behaviors were retrieved from PubMed using the search terms: "obesity," "food preference," "taste," "ingestive behavior," "weight loss medication," "anti-obesity medication," "GLP-1 analog," "tirzepatide," "liraglutide," "semaglutide." Measurement tools were studied to compare variables used to assess food intake behavior. The main outcomes from each study were analyzed to evaluate the current standing and future directions of appetitive, ingestive, and consummatory behaviors and their association with GLP-1 analogs. Thus far, studies have primarily explored the weight loss phase and report decreased short-term appetite and food intake upon treatment. However, research during the weight maintenance phase and objective measurements of food intake are notably sparse. Additionally, verbal reports have been primarily used to examine food intake, which can be susceptible to subjectivity. Elucidating the relationship between GLP-1 analogs and ingestive behavior could reveal additional parameters which contribute to their anti-obesity effects. To better understand these mechanisms, it is imperative to consider objective measurements of food intake in future studies. Several measurement tools have been adapted to measure variables of food behavior in humans, and each must be carefully considered with their strengths and limitations to develop optimal investigations. [Abstract copyright: © 2024. The Author(s).]
Original languageEnglish
JournalInternational Journal of Obesity
Early online date7 Mar 2024
DOIs
Publication statusPublished online - 7 Mar 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Keywords

  • Gastrointestinal hormones
  • Obesity
  • Weight management

Fingerprint

Dive into the research topics of 'Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities'. Together they form a unique fingerprint.

Cite this